Literature DB >> 8770915

Regulation of preadipocyte factor-1 gene expression during 3T3-L1 cell differentiation.

C M Boney1, F T Fiedorek, S R Paul, P A Gruppuso.   

Abstract

Preadipocyte factor-1 (Pref-1), a novel gene product isolated from murine preadipocyte 3T3-L1 cells, is thought to function as a negative regulator of adipocyte differentiation. We investigated the regulation of Pref-1 expression in 3T3-L1 preadipocytes during proliferation, growth arrest, and early differentiation in the presence and absence of three well described differentiation antagonists: interleukin-11 (IL-11), transforming growth factor-beta, and tumor necrosis factor-alpha. Northern blot analysis was used to determine messenger RNA (mRNA) steady state expression of Pref-1 and two differentiation-specific genes, adipsin and glycerol-3-phosphate dehydrogenase. We confirmed that Pref-1 mRNA is abundant in proliferating preadipocytes and that its expression is dramatically reduced early in differentiation. However, proliferating and growth-arrested cells treated with the differentiation inhibitor IL-11 demonstrated a modest decrease in Pref-1 mRNA abundance. Transforming growth factor-beta and tumor necrosis factor-alpha had little effect. The reduction of Pref-1 mRNA was most dramatic in differentiating preadipocytes treated with IL-11, occurring despite inhibition of adipogenesis, as judged by cell morphology and adipocyte-specific gene expression (adipsin and glycerol-3-phosphate dehydrogenase). This effect of IL-11 on Pref-1 suggests that different mechanisms are responsible for the IL-11-induced and the differentiation- associated down-regulation of Pref-1, thus dissociating Pref-1 regulation from differentiation. We conclude that Pref-1 expression is not a reliable marker of preadipocytes, and that decreased Pref-1 abundance does not function as a trigger for adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770915     DOI: 10.1210/endo.137.7.8770915

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Conditional deletions refine the embryonic requirement for Dlk1.

Authors:  Oliver K Appelbe; Aleksey Yevtodiyenko; Hilmarie Muniz-Talavera; Jennifer V Schmidt
Journal:  Mech Dev       Date:  2012-10-08       Impact factor: 1.882

Review 2.  Pasteurella multocida toxin interaction with host cells: entry and cellular effects.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure.

Authors:  Xiaoran Fu; Cristina Almenglo; Ángel Luis Fernandez; José Manuel Martínez-Cereijo; Diego Iglesias-Alvarez; Darío Duran-Muñoz; Tomás García-Caballero; Jose Ramón Gonzalez-Juanatey; Moises Rodriguez-Mañero; Sonia Eiras
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

4.  Diacylglycerol kinase delta promotes lipogenesis.

Authors:  Yulia V Shulga; Dessi Loukov; Pavlina T Ivanova; Stephen B Milne; David S Myers; Grant M Hatch; G Umeh; Divyanshi Jalan; Morgan D Fullerton; Gregory R Steinberg; Matthew K Topham; H Alex Brown; Richard M Epand
Journal:  Biochemistry       Date:  2013-10-23       Impact factor: 3.162

5.  Isolation and differentiation of chondrocytic cells derived from human embryonic stem cells using dlk1/FA1 as a novel surface marker.

Authors:  Linda Harkness; Hanna Taipaleenmaki; Amer Mahmood; Ulrik Frandsen; Anna-Marja Saamanen; Moustapha Kassem; Basem M Abdallah
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

6.  Rho/ROCK-dependent inhibition of 3T3-L1 adipogenesis by G-protein-deamidating dermonecrotic toxins: differential regulation of Notch1, Pref1/Dlk1, and β-catenin signaling.

Authors:  Yuka Bannai; Leila R Aminova; Melinda J Faulkner; Mengfei Ho; Brenda A Wilson
Journal:  Front Cell Infect Microbiol       Date:  2012-06-05       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.